Retinal Degeneration drugs in development, 2023

GlobalData tracks 76 drugs in development for Retinal Degeneration by 63 companies/universities/institutes. The top development phase for Retinal Degeneration is preclinical, with 40 drugs in that stage.

Phare Bio receives funds to advance AI drug discovery platform

Phare Bio and Collins Lab are working to develop an inaugural open-source database dedicated to AI-driven antibiotic discovery. Credit: Gorodenkoff/Shutterstock. Phare Bio, in collaboration with

September 27, 2024

Epigenomics AG publishes financial results for fiscal year 2023 – Biotech Investments

EQS-News: Epigenomics AG / Key word(s): Annual Results/Annual Report Epigenomics AG publishes financial results for fiscal year 2023 14.03.2024 / 08:00 CET/CEST The issuer is

March 15, 2024

Understanding public perception of polygenic embryo screening for IVF

Three out of four U.S. adults support the use of emerging technologies that estimate a future child’s likelihood of developing health conditions influenced by multiple

May 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.